Neuropsychological, behavioral, and quality‐of‐life outcomes in children and adolescents with sickle cell disease treated with nonmyeloablative matched sibling donor hematopoietic cell transplantation: A case series-Reference-Cited by-同舟云学术

Neuropsychological, behavioral, and quality‐of‐life outcomes in children and adolescents with sickle cell disease treated with nonmyeloablative matched sibling donor hematopoietic cell transplantation: A case series

Published:2022-07-26 Issue:10 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Fay‐McClymont Taryn B.¹²³^ORCID,Monagel Dania A.⁴^ORCID,Singh Gurpreet²,Schulte Fiona⁵,Brooks Brian L.¹²⁶⁷,MacAllister William S.¹²,Désiré Naddley⁸,Mineyko Aleksandra²⁶,Vasserman Marsha¹²,Leaker Michael T.²,Truong Tony H.²⁵^ORCID,Shah Ravi²⁵,Lewis Victor A.²⁵,Yeates Keith Owen⁷,Guilcher Gregory M. T.²⁵

Affiliation:

1. Neuropsychology/Neurosciences Program Alberta Children's Hospital Calgary Alberta Canada

2. Department of Pediatrics Cumming School of Medicine University of Calgary Calgary Alberta Canada

3. Department of Psychology Irving K. Barber Faculty of Arts and Social Sciences University of British Columbia Okanagan Kelowna British Columbia Canada

4. King Saud bin Abdulaziz University for Health Sciences King Abdullah International Medical Research Center Jeddah Saudi Arabia

5. Department of Oncology Cumming School of Medicine University of Calgary Calgary Alberta Canada

6. Department of Clinical Neurosciences Cumming School of Medicine Alberta Children's Hospital University of Calgary Calgary Alberta Canada

7. Department of Psychology University of Calgary Calgary Alberta Canada

8. Department of Psychology The Hospital for Sick Children Toronto Ontario Canada

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29893

Reference37 articles.

1. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation

2. Nonmyeloablative Matched Sibling Donor Hematopoietic Cell Transplantation in Children and Adolescents with Sickle Cell Disease

3. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease

4. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia